Log in to save to my catalogue

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Pat...

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Pat...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2561917338

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

About this item

Full title

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

Publisher

New York: Springer US

Journal title

Digestive diseases and sciences, 2022-06, Vol.67 (6), p.2299-2309

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Background and Aims
Antimicrobial therapy improves symptoms in patients with irritable bowel syndrome (IBS), but the efficacy in functional dyspepsia (FD) is largely unknown. While FD and IBS frequently overlap, it is unknown if concomitant IBS in FD alters the response to antimicrobial therapy in FD. Thus, we aimed to assess and compare the eff...

Alternative Titles

Full title

Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2561917338

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2561917338

Other Identifiers

ISSN

0163-2116

E-ISSN

1573-2568

DOI

10.1007/s10620-021-07149-1

How to access this item